Handelsbanken Fonder’s BioLife Solutions BLFS Stock Holding History

Handelsbanken Fonder’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-27,800	Closed	-$605K	–	1577
2023 Q1	$605K	Buy	27,800 +3,300	+13%	+$74.2K	﹤0.01%	916
2022 Q4	$446K	Buy	+24,500	New	+$506K	﹤0.01%	1021
2022 Q1	–	Sell	-6,900	Closed	-$257K	–	1702
2021 Q4	$257K	Buy	+6,900	New	+$296K	﹤0.01%	1652

Other funds holding BLFS

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Handelsbanken Fonder's BLFS Position: Q2 2023 in Review

Handelsbanken Fonder sold out of BioLife Solutions (BLFS) in Q2 2023, closing a stake of 27,800 shares — an estimated $605K sold.

Handelsbanken Fonder first reported a position in BLFS in Q4 2021 and held it in 3 quarters. The position peaked at $605K in Q1 2023. 156 funds tracked by Wall St. Rank hold BLFS as of Q2 2023.

Handelsbanken Fonder reported no remaining BioLife Solutions position as of Q2 2023 after selling out during the quarter.
Handelsbanken Fonder sold 27,800 BioLife Solutions shares in Q2 2023, an estimated $605K.
Handelsbanken Fonder first reported a position in BioLife Solutions in Q4 2021 and held it in 3 quarters.
Handelsbanken Fonder's BioLife Solutions position peaked at $605K in Q1 2023.
156 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2023.

Based on Handelsbanken Fonder's 13F filing for Q2 2023, filed 2 Aug 2023.